MDD POC Study GSK372475 Subjects Depressive Disease
Status:
Completed
Trial end date:
2008-10-15
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety and tolerability of GSK372475 compared with placebo in the
treatment of outpatients subjects with major depressive disorder to exhibit decreased
pleasure, interest and energy.